NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

體外診斷質量控制市場規模調查:按報價,應用,分銷商,最終用戶(∼2025年),COVID-19的累積影響

In-Vitro Diagnostics Quality Control Market Research Report by Offering, by Distributor, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 989827
出版日期 內容資訊 英文 196 Pages
商品交期: 最快1-2個工作天內
價格
體外診斷質量控制市場規模調查:按報價,應用,分銷商,最終用戶(∼2025年),COVID-19的累積影響 In-Vitro Diagnostics Quality Control Market Research Report by Offering, by Distributor, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 196 Pages
簡介

全球體外診斷質量控制市場預計將從2020年的1,095,990,000美元增長到2025年底的1,480,890,000美元。

這項研究對體外診斷質量控制的全球市場進行分類,預測收入,並分析以下每個子市場的趨勢:

根據報價,在數據管理解決方案,質量保證服務和質量控制產品中對體外診斷質量控制市場進行了調查。

通過應用,對它進行了臨床化學,凝血或止血,血液學,免疫化學,微生物學和分子診斷的研究。

由分銷商對整車廠和第三方控制製造商進行了調查。第三方控件製造商已針對獨立的製造商控件和特定於設備的控件進行了進一步調查。

最終用戶對它進行了跨實驗室,醫院,研究機構和學術機構的調查。

按地區,該調查是在美洲,亞太地區,歐洲和中東/非洲進行的。

COVID-19的累積影響:

預計COVID-19將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。我們正在進行的研究擴大了研究框架,以確保它包括潛在的COVID-19問題和潛在的未來路徑。該研究提供了對COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場勢力動態以及政府的主要干預措施的變化。更新後的調查提供了見解,分析,估計和預測,其中考慮了COVID-19對市場的影響。

報告提供了有關以下準則的見解:

  • 1. 市場滲透率:主要參與者提供的全面市場信息
  • 2. 市場開發:有利可圖的新興市場的詳細信息和市場分析
  • 3. 市場多元化:有關新產品發佈,欠發達地區,最新發展和投資的更多信息
  • 4. 競爭評估和情報:全面評估領先公司的市場份額,戰略,產品和製造能力
  • 5. 產品開發和創新:對未來技術,研發活動和新產品開發的見解

報告回答以下問題:

1.全球體外診斷質量控制市場的規模和預測是什麼?

2.在預測期內,COVID-19構成全球體外診斷質量控制市場的障礙和影響是什麼?

3.在全球體外診斷質量控制市場的預測期內,您將投資哪些產品/細分/應用/領域?

4.在全球體外診斷質量控制市場中,機會的競爭戰略窗口是什麼?

5.全球體外診斷質量控制市場趨勢技術趨勢和監管框架是什麼?

6.被認為適合進入全球體外診斷質量控制市場的模式和戰略舉措是什麼?

本報告調查了體外診斷質量控制市場,分析了市場概況,市場增長和障礙因素,市場規模趨勢以及按類型和地區劃分的預測,競爭狀況,主要公司的概況,並提供了諸如市場等全面信息。機會。

目錄

第1章前言

  • 調查目的
  • 市場細分和覆蓋範圍
  • 調查目標年度
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 簡介
  • 市場前景
  • 經銷商展望
  • 報價展望
  • 按應用程序劃分的Outlook
  • 最終用戶的Outlook
  • 區域展望
  • 競爭對手的展望

第4章市場概述

  • 簡介
  • COVID-19的累積效果

第5章市場洞察

  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 挑戰
  • 搬運工五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章提供了另一個全球體外診斷質量控制市場

  • 簡介
  • 數據管理解決方案
  • 質量保證服務
  • 質量控制產品
    • 尿液控制
    • 基於全血的控制
    • 基於全血的控制

第7章,按應用劃分的全球體外診斷質量控制市場

  • 簡介
  • 臨床化學
  • 凝血或止血
  • 血液學
  • 免疫化學
  • 微生物學
  • 分子診斷

第8章,分銷商的全球體外診斷質量控制市場

  • 簡介
  • OEM
  • 第三方控制製造商
    • 獨立的製造商管理
    • 特定於設備的控件

第9章最終用戶的全球體外診斷質量控制市場

  • 簡介
  • 臨床實驗室
  • 醫院
  • 研究與學術機構

第10章美洲體外診斷質量控制市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區體外診斷質量控制市場

  • 簡介
  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第12章歐洲,中東和非洲的體外診斷質量控制市場

  • 簡介
  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第13章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 競爭情景
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎項,獎項,擴展

第14章企業可用性簡介

  • Abbott Laboratories Inc.
  • Bio-Rad Laboratories, Inc.
  • Helena Laboratories
  • Ortho Clinical Diagnostics, Inc.
  • Randox Laboratories Ltd
  • Roche Diagnostics
  • Seracare Life Sciences, Inc.
  • Sero as
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.

第15章附錄

  • 討論指南

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-43127F7279E2

The Global In-Vitro Diagnostics Quality Control Market size was estimated at USD 1,095.99 Million in 2020 and expected to reach USD 1,169.47 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.04% to reach USD 1,648.75 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the In-Vitro Diagnostics Quality Control to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Offering, the In-Vitro Diagnostics Quality Control Market was studied across Data Management Solutions, Quality Assurance Services, and Quality Control Products. The Quality Control Products is further studied across Urine-Based Controls, Whole-Blood-Based Controls, and Whole-Blood-Based Controls.

Based on Distributor, the In-Vitro Diagnostics Quality Control Market was studied across OEM and Third-Party Control Manufacturers. The Third-Party Control Manufacturers is further studied across Independent Manufacturer Controls and Instrument-Specific Controls.

Based on Application, the In-Vitro Diagnostics Quality Control Market was studied across Clinical Chemistry, Coagulation or Hemostasis, Hematology, Immunochemistry, Microbiology, and Molecular Diagnostics.

Based on End User, the In-Vitro Diagnostics Quality Control Market was studied across Clinical Laboratories, Hospitals, and Research & Academic Institutes.

Based on Geography, the In-Vitro Diagnostics Quality Control Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the In-Vitro Diagnostics Quality Control Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global In-Vitro Diagnostics Quality Control Market, including Abbott Laboratories Inc., Bio-Rad Laboratories, Inc., Helena Laboratories, Ortho Clinical Diagnostics, Inc., Randox Laboratories Ltd, Roche Diagnostics, Seracare Life Sciences, Inc., Sero as, Technopath Clinical Diagnostics, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global In-Vitro Diagnostics Quality Control Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global In-Vitro Diagnostics Quality Control Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In-Vitro Diagnostics Quality Control Market?
  • 4. What is the competitive strategic window for opportunities in the Global In-Vitro Diagnostics Quality Control Market?
  • 5. What are the technology trends and regulatory frameworks in the Global In-Vitro Diagnostics Quality Control Market?
  • 6. What is the market share of the leading vendors in the Global In-Vitro Diagnostics Quality Control Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global In-Vitro Diagnostics Quality Control Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Distributor Outlook
  • 3.4. Offering Outlook
  • 3.5. Application Outlook
  • 3.6. End User Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Geriatric population and prevalence of chronic and infectious diseases
      • 5.1.1.2. Rise in the number of accredited clinical laboratories and adoption of third-party quality controls
      • 5.1.1.3. Demand for advanced diagnostics for sensitive reports and accurate diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of IVD quality control services
      • 5.1.2.2. Unfavorable reimbursement
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in the demand for multi-analyte controls
      • 5.1.3.2. Growth opportunities in emerging countries
    • 5.1.4. Challenges
      • 5.1.4.1. Limited regulations for clinical laboratory accreditation in several emerging countries
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. In-Vitro Diagnostics Quality Control Market, by Offering

  • 6.1. Introduction
  • 6.2. Data Management Solutions
  • 6.3. Quality Assurance Services
  • 6.4. Quality Control Products
    • 6.4.1. Urine-Based Controls
    • 6.4.2. Whole-Blood-Based Controls
    • 6.4.3. Whole-Blood-Based Controls

7. In-Vitro Diagnostics Quality Control Market, by Distributor

  • 7.1. Introduction
  • 7.2. OEM
  • 7.3. Third-Party Control Manufacturers
    • 7.3.1. Independent Manufacturer Controls
    • 7.3.2. Instrument-Specific Controls

8. In-Vitro Diagnostics Quality Control Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Chemistry
  • 8.3. Coagulation or Hemostasis
  • 8.4. Hematology
  • 8.5. Immunochemistry
  • 8.6. Microbiology
  • 8.7. Molecular Diagnostics

9. In-Vitro Diagnostics Quality Control Market, by End User

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
  • 9.3. Hospitals
  • 9.4. Research & Academic Institutes

10. Americas In-Vitro Diagnostics Quality Control Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States
    • 10.6.1. California
    • 10.6.2. Florida
    • 10.6.3. Illinois
    • 10.6.4. New York
    • 10.6.5. Ohio
    • 10.6.6. Pennsylvania
    • 10.6.7. Texas

11. Asia-Pacific In-Vitro Diagnostics Quality Control Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa In-Vitro Diagnostics Quality Control Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Market Share Analysis, By Company
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Abbott Laboratories Inc.
  • 14.2. Bio-Rad Laboratories, Inc.
  • 14.3. Helena Laboratories
  • 14.4. Ortho Clinical Diagnostics, Inc.
  • 14.5. Randox Laboratories Ltd
  • 14.6. Roche Diagnostics
  • 14.7. Seracare Life Sciences, Inc.
  • 14.8. Sero as
  • 14.9. Technopath Clinical Diagnostics
  • 14.10. Thermo Fisher Scientific Inc.

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2026
  • FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2020 VS 2026 (%)
  • FIGURE 25. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2026
  • FIGURE 27. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 36. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 38. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2026 (USD MILLION)
  • FIGURE 39. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, 2018-2026 (USD MILLION)
  • FIGURE 41. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 42. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 43. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 44. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, 2018-2026 (USD MILLION)
  • FIGURE 45. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 46. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 47. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 48. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD MILLION)
  • FIGURE 49. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 50. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 51. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2026
  • FIGURE 53. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2026 (USD MILLION)
  • FIGURE 54. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 55. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 56. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 57. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2018-2026 (USD MILLION)
  • FIGURE 58. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 59. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 60. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 62. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. CALIFORNIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. FLORIDA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. ILLINOIS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. NEW YORK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. OHIO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. PENNSYLVANIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. TEXAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 75. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 76. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 77. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 80. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 82. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 83. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 84. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 85. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 86. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 87. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 88. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 89. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 90. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 91. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 92. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 93. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 94. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 95. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 96. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 97. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 98. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 99. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: FPNV POSITIONING MATRIX
  • FIGURE 100. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 101. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 102. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. CALIFORNIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. CALIFORNIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. CALIFORNIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. CALIFORNIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. FLORIDA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. FLORIDA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. FLORIDA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. FLORIDA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. ILLINOIS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. ILLINOIS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. ILLINOIS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. ILLINOIS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. NEW YORK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. NEW YORK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. NEW YORK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. NEW YORK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. OHIO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. OHIO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. OHIO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. OHIO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. PENNSYLVANIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. PENNSYLVANIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. PENNSYLVANIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. PENNSYLVANIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. TEXAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. TEXAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. TEXAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. TEXAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 132. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 133. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 134. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 135. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 136. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 137. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 138. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 139. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 140. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 141. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 142. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 143. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 144. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 145. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 146. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 147. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 148. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 149. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 150. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 151. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 152. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 153. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 154. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 155. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 156. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 157. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 158. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 159. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 160. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 161. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 162. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 163. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 164. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 165. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 166. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SCORES
  • TABLE 167. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: BUSINESS STRATEGY
  • TABLE 168. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: PRODUCT SATISFACTION
  • TABLE 169. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: RANKING
  • TABLE 170. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 171. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SHARE, BY COMPANY, 2020
  • TABLE 172. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: MERGER & ACQUISITION
  • TABLE 173. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 174. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 175. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: INVESTMENT & FUNDING
  • TABLE 176. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 177. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: LICENSE & PRICING
  • TABLE 178. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: CONTACT DETAILS